These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 16839777)
1. Preparation and characterization of truncated human lipopolysaccharide-binding protein in Escherichia coli. Kohara J; Tsuneyoshi N; Gauchat JF; Kimoto M; Fukudome K Protein Expr Purif; 2006 Oct; 49(2):276-83. PubMed ID: 16839777 [TBL] [Abstract][Full Text] [Related]
2. Comparison of lipopolysaccharide-binding functions of CD14 and MD-2. Koraha J; Tsuneyoshi N; Kimoto M; Gauchat JF; Nakatake H; Fukudome K Clin Diagn Lab Immunol; 2005 Nov; 12(11):1292-7. PubMed ID: 16275943 [TBL] [Abstract][Full Text] [Related]
3. LBP and CD14 secreted in tears by the lacrimal glands modulate the LPS response of corneal epithelial cells. Blais DR; Vascotto SG; Griffith M; Altosaar I Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4235-44. PubMed ID: 16249503 [TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide-binding protein-mediated Toll-like receptor 4 dimerization enables rapid signal transduction against lipopolysaccharide stimulation on membrane-associated CD14-expressing cells. Tsukamoto H; Fukudome K; Takao S; Tsuneyoshi N; Kimoto M Int Immunol; 2010 Apr; 22(4):271-80. PubMed ID: 20133493 [TBL] [Abstract][Full Text] [Related]
5. Low potency of Chlamydophila LPS to activate human mononuclear cells due to its reduced affinities for CD14 and LPS-binding protein. Tsutsumi-Ishii Y; Shimada K; Daida H; Toman R; Nagaoka I Int Immunol; 2008 Feb; 20(2):199-208. PubMed ID: 18056918 [TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide-binding protein down-regulates the expression of interleukin-6 by human gingival fibroblast. Ren L; Leung WK; Loo TW; Jin L J Periodontal Res; 2005 Oct; 40(5):407-16. PubMed ID: 16105094 [TBL] [Abstract][Full Text] [Related]
7. Stable transduction of bovine TLR4 and bovine MD-2 into LPS-nonresponsive cells and soluble CD14 promote the ability to respond to LPS. Sauter KS; Brcic M; Franchini M; Jungi TW Vet Immunol Immunopathol; 2007 Jul; 118(1-2):92-104. PubMed ID: 17559944 [TBL] [Abstract][Full Text] [Related]
8. An amino-terminal fragment of human lipopolysaccharide-binding protein retains lipid A binding but not CD14-stimulatory activity. Theofan G; Horwitz AH; Williams RE; Liu PS; Chan I; Birr C; Carroll SF; Mészáros K; Parent JB; Kasler H J Immunol; 1994 Apr; 152(7):3623-9. PubMed ID: 7511654 [TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide recognition protein, MD-2, facilitates cellular uptake of E. coli-derived plasmid DNA in synovium. Kolka JA; Vreede AP; Roessler BJ J Gene Med; 2005 Jul; 7(7):956-64. PubMed ID: 15772934 [TBL] [Abstract][Full Text] [Related]
10. Human MD-2 discrimination of meningococcal lipid A structures and activation of TLR4. Zimmer SM; Zughaier SM; Tzeng YL; Stephens DS Glycobiology; 2007 Aug; 17(8):847-56. PubMed ID: 17545685 [TBL] [Abstract][Full Text] [Related]
11. The lipopolysaccharide-recognition mechanism in cells expressing TLR4 and CD14 but lacking MD-2. Ohnishi T; Muroi M; Tanamoto K FEMS Immunol Med Microbiol; 2007 Oct; 51(1):84-91. PubMed ID: 17614960 [TBL] [Abstract][Full Text] [Related]
12. Reactivity of murine and human recombinant LPS-binding protein (LBP) within LPS and gram negative bacteria. Lengacher S; Jongeneel CV; Le Roy D; Lee JD; Kravchenko V; Ulevitch RJ; Glauser MP; Heumann D J Inflamm; 1995-1996; 47(4):165-72. PubMed ID: 9144073 [TBL] [Abstract][Full Text] [Related]
14. Penta-acylated lipopolisaccharide binds to murine MD-2 but does not induce the oligomerization of TLR4 required for signal transduction. Tsuneyoshi N; Kohara J; Bahrun U; Saitoh S; Akashi S; Gauchat JF; Kimoto M; Fukudome K Cell Immunol; 2006 Nov; 244(1):57-64. PubMed ID: 17420011 [TBL] [Abstract][Full Text] [Related]
15. Modulatory effects of sCD14 and LBP on LPS-host cell interactions. Kitchens RL; Thompson PA J Endotoxin Res; 2005; 11(4):225-9. PubMed ID: 16176659 [TBL] [Abstract][Full Text] [Related]
16. The Toll-like receptor 4 region Glu24-Pro34 is critical for interaction with MD-2. Nishitani C; Mitsuzawa H; Hyakushima N; Sano H; Matsushima N; Kuroki Y Biochem Biophys Res Commun; 2005 Mar; 328(2):586-90. PubMed ID: 15694388 [TBL] [Abstract][Full Text] [Related]
17. Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerization. Saitoh S; Akashi S; Yamada T; Tanimura N; Kobayashi M; Konno K; Matsumoto F; Fukase K; Kusumoto S; Nagai Y; Kusumoto Y; Kosugi A; Miyake K Int Immunol; 2004 Jul; 16(7):961-9. PubMed ID: 15184344 [TBL] [Abstract][Full Text] [Related]
18. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Hajjar AM; Ernst RK; Tsai JH; Wilson CB; Miller SI Nat Immunol; 2002 Apr; 3(4):354-9. PubMed ID: 11912497 [TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide (LPS) binding protein catalyzes binding of LPS to lipoproteins. Wurfel MM; Wright SD Prog Clin Biol Res; 1995; 392():287-95. PubMed ID: 8524933 [TBL] [Abstract][Full Text] [Related]
20. A synthetic lipopolysaccharide-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood. de Haas CJ; van der Tol ME; Van Kessel KP; Verhoef J; Van Strijp JA J Immunol; 1998 Oct; 161(7):3607-15. PubMed ID: 9759883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]